Skip to main content
Clinical Trials/EUCTR2019-001125-27-BE
EUCTR2019-001125-27-BE
Active, not recruiting
Phase 1

Erector Spinae plane block for minimal invasive mitral valve surgery. A double blind, prospective randomized placebo-controlled trial.

niversity Hospitals Leuven0 sites72 target enrollmentApril 29, 2019
Drugsnaropin

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Hospitals Leuven
Enrollment
72
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 29, 2019
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity Hospitals Leuven

Eligibility Criteria

Inclusion Criteria

  • 18\-75 years of age
  • BMI \<\= 35
  • Euroscore \<\= 3
  • Patient is scheduled for elective mitral valve surgery
  • patient enrolled in the fast\-track program
  • patient is able to provide written informed consent
  • patient understands the use of morphine IV PCA
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes

Exclusion Criteria

  • Patient refusal
  • inability to operate a PCA system
  • planned admission to Intensice Care Unit
  • Chronic opioid use
  • Obstructive sleep apnea syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials